Caroline Derne, MSc.

 

Caroline Derne holds a Master Degree in Health Engineering, specialized in Drug Development. She is managing Clinical Studies from phase 1 to phase 3 since 2002, covering scientific and operational activities. She has experience in several therapeutic areas in Phase I, II, III and in paediatric development. She defines herself as empathic, communicative, and problem solver.

 

Caroline started her career in Contract Research Organizations as a Clinical Research Associate, responsible for setting up and monitoring clinical sites in France, Belgium and Italy, for major pharmaceutical companies. She moved to Study Management positions in Oncology at Bristol-Myers Squibb, where she set up and led phase 1 to phase 3 trial over France and South Africa. Then she evolved through global positions at Novartis Pharma A.G, in Oncology and Translational Medicine. As a Senior Clinical Scientist at Actelion, she coordinated the scientific set up of the Paediatric Studies program. Subsequently she worked for Amzell B.V, a small company at the time, to move forward the pipeline in clinical phase.

 

Caroline believes in science; she enjoys working in collaborative teams and projectized environment. She founded CDBMCo to provide Pharmaceutical Companies with clinical trial expertise and foster success in their programs.

Caroline Derne